Wolverine Asset Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-600
Closed -$6.07K – 1873
2023
Q3
$6.07K Hold
600
– – ﹤0.01% 1539
2023
Q2
$7.5K Buy
+600
New +$7.15K ﹤0.01% 1425
2023
Q1
– Sell
-5
Closed -$64 – 1977
2022
Q4
$53 Sell
5
-10,772
-100% -$104K ﹤0.01% 2071
2022
Q3
$104K Buy
+10,777
New +$143K ﹤0.01% 1422

Other funds holding HCAT

Wolverine Asset Management's HCAT Position: Q4 2023 in Review

Wolverine Asset Management sold out of Health Catalyst (HCAT) in Q4 2023, closing a stake of 600 shares — an estimated $6.07K sold.

Wolverine Asset Management first reported a position in HCAT in Q3 2022 and held it in 4 quarters. The position peaked at $104K in Q3 2022. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2023.

  • Wolverine Asset Management reported no remaining Health Catalyst position as of Q4 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 600 Health Catalyst shares in Q4 2023, an estimated $6.07K.
  • Wolverine Asset Management first reported a position in Health Catalyst in Q3 2022 and held it in 4 quarters.
  • Wolverine Asset Management's Health Catalyst position peaked at $104K in Q3 2022.
  • 167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2023.

Based on Wolverine Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.